Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-009394

Director bought 1,881.71 shares at $11.82 ($22,242)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haddadin Yezan Munther Director 2024-03-28 Purchase +1,881.71 $11.82 $22,242 5,048.71 D
Open-market purchases · 1,881.71 sh · avg $11.82 · $22,242
Loading xslF345X05/form4-03292024_020304.xml…